These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [A current view on dopamine receptor agonists in the treatment of Parkinson's disease]. Titova NV Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(9):76-83. PubMed ID: 26525820 [TBL] [Abstract][Full Text] [Related]
29. Postoperative hyperthermic syndrome following antiparkinsonian drugs withdrawal: the pitfall of enteral refeeding. Casier I; Jeanjean A; Hantson P Anaesth Intensive Care; 2013 Nov; 41(6):814-5. PubMed ID: 24180734 [No Abstract] [Full Text] [Related]
30. Neuroleptic malignant syndrome postoperative onset due to levodopa withdrawal. Young CC; Kaufman BS J Clin Anesth; 1995 Dec; 7(8):652-6. PubMed ID: 8747565 [TBL] [Abstract][Full Text] [Related]
31. Pramipexole-induced limb dystonia and its associated complex regional pain syndrome in idiopathic Parkinson's disease: A case report. Park D Medicine (Baltimore); 2017 Jul; 96(28):e7530. PubMed ID: 28700507 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease. Sato Y; Asoh T; Metoki N; Satoh K J Neurol Neurosurg Psychiatry; 2003 May; 74(5):574-6. PubMed ID: 12700295 [TBL] [Abstract][Full Text] [Related]
33. Prevention and treatment of malignant syndrome in Parkinson's disease: a consensus statement of the malignant syndrome research group. Ikebe S; Harada T; Hashimoto T; Kanazawa I; Kuno S; Mizuno Y; Mizuta E; Murata M; Nagatsu T; Nakamura S; Takubo H; Yanagisawa N; Narabayashi H Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S47-9. PubMed ID: 12735915 [TBL] [Abstract][Full Text] [Related]
34. [Severe leg edema associated with the use of dopaminergic drugs in Parkinson's disease. Report of one case]. Miranda C M; Hudson A L Rev Med Chil; 2017 Dec; 145(12):1624-1625. PubMed ID: 29652961 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of pramipexole extended-release in Parkinson's disease: a review based on meta-analysis of randomized controlled trials. Shen T; Ye R; Zhang B Eur J Neurol; 2017 Jun; 24(6):835-843. PubMed ID: 28480621 [TBL] [Abstract][Full Text] [Related]
39. Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged-release. Rascol O Eur J Neurol; 2011 Mar; 18 Suppl 1():3-10. PubMed ID: 21255197 [TBL] [Abstract][Full Text] [Related]